XML 124 R103.htm IDEA: XBRL DOCUMENT v3.24.3
SHARE-BASED PAYMENTS - Narrative (Detail) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 22, 2022
Dec. 31, 2021
Aug. 13, 2021
Dec. 15, 2017
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2020
Jul. 23, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares outstanding (in shares)         6,250,493   6,319,513 6,250,493    
Grant date fair value of nonvested stock         $ 0.8   $ 0.6 $ 0.8    
Unrecognized compensation cost related to nonvested stock             $ 0.4      
ESPP                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock shares available for future issuance (in shares)             8,284      
Number of shares pursuant to stock options granted (in shares)             64,286      
Common stock purchase price as a percentage of market value (in percentage)             85.00%      
Shares issued under plan (in shares)             0 0    
Selling, general and administrative                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation expense         $ 0.2 $ 0.5 $ 0.6      
Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares surrendered (in shares)             0      
Non vested stock compensation expense             $ 0.6 $ 0.8    
Weighted average period of cost expected to be expensed (in years)             8 months 12 days      
Restricted Stock | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Term of restriction period (in years)             1 year      
Restricted Stock | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Term of restriction period (in years)             5 years      
Director | Restricted Stock | Reith v. Lichtenstein                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares surrendered (in shares)     353,571              
2020 Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares available for grant (in shares)                   529,821
Common stock shares available for future issuance (in shares)             739,265      
2010 Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock shares available for future issuance (in shares)                   393,015
Common stock, shares outstanding (in shares)                   113,627
2010 Plan | Director | Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Restricted stock award vested (in shares)       428,571            
2010 Plan | Director | Market Performance Based Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Restricted stock award granted (in shares)       160,714            
Restricted stock award vested (in shares)                 107,142  
2010 Plan | Nonemployee Director                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares surrendered (in shares) 353,571 353,571